Cetirizine Hydrochloride Solution
Product Images NDC 69452-426

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cetirizine Hydrochloride (NDC 69452-426). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image001 (Image001)

Image001 (Image001)
This text contains information about a prescription drug with the active ingredient Cetirizine Hydrochloride in oral solution form. Each mL of the solution contains 1 mg of cetirizine hydrochloride. The drug is for oral use only and should be stored between 20°-25°C (68°-77°F) with excursions permitted to 15°-30°C (59°-86°F) or refrigerated at 2°-8°C (36°-46°F). The product should be dispensed in tight, light-resistant containers. For dosage and further instructions, refer to the accompanying prescribing information. In case of a serious adverse event, contact Bionpharma Inc. The drug is distributed by Bionpharma Inc. and is made in India.*
FDA Label Image

Image002 (Image002)

Image002 (Image002)
This is a description of Cetirizine Hydrochloride Oral Solution, USP, with a concentration of 1 mg/1 mL. The solution is intended for oral use only and is available in a 1 pint (480 mL) bottle. Each mL contains 1 mg of cetirizine hydrochloride. It provides guidance on storage conditions and how to report adverse events. The solution is distributed by Bionpharma Inc. and manufactured in India.*
FDA Label Image

Chemical Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.